[Treatment of Concomitant Intra-abdominal Malignancy and Abdominal Aortic Aneurysm]

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Feb 28;43(1):37-41. doi: 10.3881/j.issn.1000-503X.12597.
[Article in Chinese]

Abstract

Objective To explore the outcomes in patients who receive the endovascular abdominal aortic aneurysm repair(EVAR)and have concomitant intra-abdominal malignancy.Methods Between January 2014 and December 2019,all the patients who underwent surgery for malignancy and/or EVAR were retrospectively reviewed.Results Twenty-eight abdominal aortic aneurysm(AAA)patients with concomitant intra-abdominal malignancy were included.The patients were treated by two-stage operation and the priority was given for EVAR in 21 patients.There was no perioperative death or major complications.In the follow-up,one patient developed graft thrombosis and one had type Ⅱ endoleak.There was no AAA-associated death.Conclusions It is preferred that EVAR should come first followed by operation for malignancy.Details of treatment strategy still need further investigation.

Keywords: abdominal aortic aneurysm; concomitant intra-abdominal malignancy; endovascular abdominal aortic aneurysm repair.

MeSH terms

  • Abdominal Neoplasms* / complications
  • Abdominal Neoplasms* / surgery
  • Aortic Aneurysm, Abdominal* / complications
  • Aortic Aneurysm, Abdominal* / surgery
  • Blood Vessel Prosthesis Implantation*
  • Endovascular Procedures*
  • Humans
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome